Oragenics, Inc.
OGEN
$1.11
-$0.006-0.54%
AMEX
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | 0.00 | 7.50K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | 0.00 | 7.50K |
| Cost of Revenue | 3.34M | 3.79M | 4.11M | 13.49M | 13.38M |
| Gross Profit | -3.34M | -3.79M | -4.11M | -13.49M | -13.37M |
| SG&A Expenses | 6.20M | 6.33M | 6.44M | 6.51M | 6.28M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 9.53M | 10.12M | 10.56M | 20.00M | 19.66M |
| Operating Income | -9.53M | -10.12M | -10.56M | -20.00M | -19.66M |
| Income Before Tax | -10.30M | -10.33M | -10.57M | -19.97M | -19.52M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -10.30 | -10.33 | -10.57 | -19.97 | -19.52 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -10.30M | -10.33M | -10.57M | -19.97M | -19.52M |
| EBIT | -9.53M | -10.12M | -10.56M | -20.00M | -19.66M |
| EBITDA | -5.78M | -8.08M | -10.53M | -19.98M | -19.64M |
| EPS Basic | -26.51 | -38.67 | -56.05 | -195.30 | -209.62 |
| Normalized Basic EPS | -16.57 | -24.17 | -35.03 | -122.07 | -131.01 |
| EPS Diluted | -26.51 | -38.67 | -56.05 | -195.30 | -209.62 |
| Normalized Diluted EPS | -16.57 | -24.17 | -35.03 | -122.07 | -131.01 |
| Average Basic Shares Outstanding | 1.95M | 1.37M | 882.30K | 571.40K | 432.30K |
| Average Diluted Shares Outstanding | 1.95M | 1.37M | 882.30K | 571.40K | 432.30K |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |